institutionid,scoredate,scoretype,aspectname,scorevalue,gvkey,ticker,companyname
4558282,2013-09-12,S&P Global ESG Score,S&P Global ESG Score,78,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Chemical Oxygen Demand,73,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Climate Change Governance,90,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Climate Strategy Impacts,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Climate-Related Management Incentives,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Coverage of Environmental Management Policy,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Direct Greenhouse Gas Emissions (Scope 1),80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,EMS: Certification/ Audit/ Verification,73,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,EP - Biological Oxygen Demand,47,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,EP - Electricity Purchased,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Emissions Reduction Targets,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Energy Use,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Environmental Reporting - Materiality,50,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Environmental Reporting - Quantitative Data,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Financial Opportunities Arising from Climate Change,20,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Financial Risks of Climate Change,20,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Hazardous Waste,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Low-Carbon Products,0,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,NOx Emissions,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,SOx Emissions,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Volatile Organic Compounds Emissions,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Waste Disposal,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Water Use,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Analysis of Risks,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Audit Conflict of Interest,86,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Board Effectiveness,60,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Board Gender Diversity,4,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,CEO-to-Employee Pay Ratio,0,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Codes of Conduct: Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Corporate Governance Policy,88,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Critical Supplier Identification,95,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Customer Feedback Process,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Customer Satisfaction Measurement,28,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Direct-to-Consumer Marketing,0,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Direct-to-Consumer Marketing: OPDP,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Direct-to-Consumer Marketing: Policies,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,ESG Integration in SCM Strategy,83,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Ethical Marketing - Complaints Tracking,70,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Open Innovation,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Opportunities,60,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Process Innovations,50,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Product Innovations (Healthcare),43,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,R&D Core or Basic Research,26,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,R&D Development Stages,62,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,R&D Ideation or Applied Research,86,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,R&D Launch,26,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,R&D Post-Launch,50,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,R&D Spending,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Reporting on breaches,25,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Responsibilities and Committees,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Responsibility Risk & Crisis Management,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Risk Response Strategy,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Sales Channels Variety & Innovation,49,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Sales Effectiveness Targets,61,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Sensitivity Analysis & Stress Testing,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Service Orientation,56,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Supplier Risk Management Measures,75,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Supply Chain Risk Exposure,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Supply Chain Transparency & Reporting,10,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Transparency of Executive Compensation,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Access to Genetic Resources,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Access to Healthcare Programs (Products),100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Balance of Variable Compensation Based on Corporate and I,60,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Benefits Sharing,75,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Bioethics Policy,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Business and Human Rights,,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,CEO Compensation - Success Metrics,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Contribution to Increasing Healthcare Efficiency,65,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Corporate Citizenship Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Coverage of Employees through Predefined Performance Appr,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Employee Support Programs,85,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Fair Pricing,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Health Management,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Healthy Lifestyle Incentive,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Human Capital Performance Indicators,20,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Human Resource Skill Mapping and Developing Process,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,50,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Measure Contribution to Health Outcome,46,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Measuring Benefits,50,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Network Orientation,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Partnerships for Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Payout Type of Total Performance-Related Compensation,0,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Percentage of Performance Related Compensation for each E,40,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Personal and Organizational Learning and Development,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Social Reporting - Materiality,32,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Social Reporting - Quantitative Data,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Stakeholder Engagement Governance,57,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Stakeholder Engagement Implementation,95,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Stakeholder Engagement Review,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Trend of Employee Wellbeing,0,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Volume,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Workforce Breakdown: Gender,48,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Dimension,Economic Governance Dimension,77,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Dimension,Environmental Dimension,81,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Dimension,Social Dimension,79,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Climate Strategy,70,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Environmental Policy & Management Systems,89,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Environmental Reporting,88,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Operational Eco-Efficiency,76,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Business Ethics,89,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Corporate Governance,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Customer Relationship Management,67,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Innovation Management,61,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Marketing Practices,79,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Risk & Crisis Management,97,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Supply Chain Management,78,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Addressing Cost Burden,73,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Bioethics,93,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Corporate Citizenship & Philanthropy,90,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Health Outcome Contribution,81,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Human Capital Development,62,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Labor Practice Indicators,74,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Occupational Health & Safety,95,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Social Reporting,83,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Stakeholder Engagement,86,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Talent Attraction & Retention,65,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,S&P Global ESG Score,S&P Global ESG Score,78,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Chemical Oxygen Demand,73,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Climate Change Governance,90,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Climate Strategy Impacts,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Climate-Related Management Incentives,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Coverage of Environmental Management Policy,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Direct Greenhouse Gas Emissions (Scope 1),80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,EMS: Certification/ Audit/ Verification,73,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,EP - Biological Oxygen Demand,47,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,EP - Electricity Purchased,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Emissions Reduction Targets,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Energy Use,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Environmental Reporting - Materiality,50,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Environmental Reporting - Quantitative Data,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Financial Opportunities Arising from Climate Change,20,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Financial Risks of Climate Change,20,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Hazardous Waste,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Low-Carbon Products,0,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,NOx Emissions,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,SOx Emissions,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Volatile Organic Compounds Emissions,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Waste Disposal,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Water Use,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Analysis of Risks,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Audit Conflict of Interest,86,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Board Effectiveness,60,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Board Gender Diversity,4,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,CEO-to-Employee Pay Ratio,0,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Codes of Conduct: Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Corporate Governance Policy,88,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Critical Supplier Identification,95,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Customer Feedback Process,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Customer Satisfaction Measurement,28,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Direct-to-Consumer Marketing,0,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Direct-to-Consumer Marketing: OPDP,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Direct-to-Consumer Marketing: Policies,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,ESG Integration in SCM Strategy,83,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Ethical Marketing - Complaints Tracking,70,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Open Innovation,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Opportunities,60,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Process Innovations,50,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Product Innovations (Healthcare),43,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,R&D Core or Basic Research,26,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,R&D Development Stages,62,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,R&D Ideation or Applied Research,86,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,R&D Launch,26,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,R&D Post-Launch,50,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,R&D Spending,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Reporting on breaches,25,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Responsibilities and Committees,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Responsibility Risk & Crisis Management,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Risk Response Strategy,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Sales Channels Variety & Innovation,49,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Sales Effectiveness Targets,61,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Sensitivity Analysis & Stress Testing,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Service Orientation,56,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Supplier Risk Management Measures,75,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Supply Chain Risk Exposure,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Supply Chain Transparency & Reporting,10,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Transparency of Executive Compensation,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Access to Genetic Resources,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Access to Healthcare Programs (Products),100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Balance of Variable Compensation Based on Corporate and I,60,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Benefits Sharing,75,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Bioethics Policy,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Business and Human Rights,,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,CEO Compensation - Success Metrics,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Contribution to Increasing Healthcare Efficiency,65,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Corporate Citizenship Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Coverage of Employees through Predefined Performance Appr,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Employee Support Programs,85,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Fair Pricing,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Health Management,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Healthy Lifestyle Incentive,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Human Capital Performance Indicators,20,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Human Resource Skill Mapping and Developing Process,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,50,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Measure Contribution to Health Outcome,46,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Measuring Benefits,50,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Network Orientation,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Partnerships for Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Payout Type of Total Performance-Related Compensation,0,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Percentage of Performance Related Compensation for each E,40,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Personal and Organizational Learning and Development,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Social Reporting - Materiality,32,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Social Reporting - Quantitative Data,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Stakeholder Engagement Governance,57,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Stakeholder Engagement Implementation,95,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Stakeholder Engagement Review,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Trend of Employee Wellbeing,0,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Volume,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Question,Workforce Breakdown: Gender,48,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Dimension,Economic Governance Dimension,77,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Dimension,Environmental Dimension,81,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Dimension,Social Dimension,79,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Climate Strategy,70,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Environmental Policy & Management Systems,89,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Environmental Reporting,88,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Operational Eco-Efficiency,76,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Business Ethics,89,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Corporate Governance,80,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Customer Relationship Management,67,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Innovation Management,61,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Marketing Practices,79,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Risk & Crisis Management,97,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Supply Chain Management,78,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Addressing Cost Burden,73,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Bioethics,93,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Corporate Citizenship & Philanthropy,90,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Health Outcome Contribution,81,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Human Capital Development,62,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Labor Practice Indicators,74,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Occupational Health & Safety,95,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Social Reporting,83,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Stakeholder Engagement,86,016101,ABBV,AbbVie Inc.
4558282,2013-09-12,Criteria,Talent Attraction & Retention,65,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,S&P Global ESG Score,S&P Global ESG Score,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Chemical Oxygen Demand,73,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Climate Change Governance,90,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Climate Strategy Impacts,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Climate-Related Management Incentives,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Coverage of Environmental Management Policy,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Direct Greenhouse Gas Emissions (Scope 1),100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,EMS: Certification/ Audit/ Verification,54,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,EP - Biological Oxygen Demand,73,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,EP - Electricity Purchased,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Emissions Reduction Targets,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Energy Use,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Environmental Reporting - Materiality,59,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Environmental Reporting - Quantitative Data,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Financial Opportunities Arising from Climate Change,20,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Financial Risks of Climate Change,20,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Hazardous Waste,31,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 2),90,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 3),83,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Low-Carbon Products,,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,NOx Emissions,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,SOx Emissions,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Volatile Organic Compounds Emissions,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Waste Disposal,69,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Water Use,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Analysis of Risks,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Audit Conflict of Interest,81,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Board Diversity Policy,60,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Board Effectiveness,48,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Board Gender Diversity,4,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,CEO-to-Employee Pay Ratio,0,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Codes of Conduct: Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Compliance to Regulatory Standards,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Corporate Governance Policy,88,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Critical Supplier Identification,98,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Customer Feedback Process,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Customer Satisfaction Measurement,64,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Direct-to-Consumer Marketing,0,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Direct-to-Consumer Marketing: OPDP,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Direct-to-Consumer Marketing: Policies,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Ethical Marketing - Complaints Tracking,85,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Expenses Associated with Product Recalls,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Open Innovation,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Opportunities,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Process Innovations,50,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Product Innovations (Healthcare),50,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Product Recalls (Health Care),90,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,R&D Core or Basic Research,74,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,R&D Development Stages,90,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,R&D Ideation or Applied Research,90,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,R&D Launch,58,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,R&D Post-Launch,70,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,R&D Spending,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Responsibilities and Committees,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Responsibility Risk & Crisis Management,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Risk Response Strategy,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Sales Channels Variety & Innovation,57,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Sales Effectiveness Targets,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Sensitivity Analysis & Stress Testing,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Service Orientation,71,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Supplier Risk Management Measures,70,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Supply Chain Risk Exposure,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Supply Chain Transparency & Reporting,54,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Tax Reporting,50,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Tax Strategy and Governance,0,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Taxation Governance & Risks,25,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Transparency of Executive Compensation,75,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Access to Genetic Resources,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Access to Healthcare Programs (Products),100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Balance of Variable Compensation Based on Corporate and I,70,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Benefits Sharing,75,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Bioethics Policy,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Business and Human Rights,81,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,CEO Compensation - Success Metrics,52,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Contribution to Increasing Healthcare Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Corporate Citizenship Strategy,90,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Coverage of Employees through Predefined Performance Appr,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Employee Development Programs,60,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Employee Support Programs,85,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Employee Turnover Rate,75,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Fair Pricing,92,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Gender Pay Indicators,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,HTA Support of Value Proposition,25,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Health Management,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Healthy Lifestyle Incentive,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Human Capital Performance Indicators,40,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Human Capital Return on Investment,77,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Labor KPIs - Layoffs,50,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,87,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Measure Contribution to Health Outcome,52,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Measuring Benefits,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Network Orientation,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Occupational Illness Frequency Rate (OIFR) - Employees,99,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Partnerships for Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Percentage of Performance Related Compensation for each E,0,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Public Commitment to Human Rights,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Return on Employee Development Investment,25,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Social Reporting - Materiality,35,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Social Reporting - Quantitative Data,42,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Stakeholder Engagement Governance,78,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Stakeholder Engagement Implementation,95,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Stakeholder Engagement Review,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Training & Development Inputs,25,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Trend of Employee Wellbeing,48,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Volume,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Workforce Breakdown: Gender,70,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Dimension,Economic Governance Dimension,82,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Dimension,Environmental Dimension,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Dimension,Social Dimension,79,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Climate Strategy,77,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Environmental Policy & Management Systems,82,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Environmental Reporting,85,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Operational Eco-Efficiency,76,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Business Ethics,85,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Corporate Governance,75,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Customer Relationship Management,81,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Innovation Management,75,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Marketing Practices,86,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Product Quality & Recall Management,98,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Risk & Crisis Management,97,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Supply Chain Management,87,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Tax Strategy,44,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Addressing Cost Burden,71,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Bioethics,93,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Corporate Citizenship & Philanthropy,98,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Health Outcome Contribution,83,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Human Capital Development,43,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Labor Practice Indicators,90,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Occupational Health & Safety,97,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Social Reporting,69,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Stakeholder Engagement,92,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Talent Attraction & Retention,69,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,S&P Global ESG Score,S&P Global ESG Score,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Chemical Oxygen Demand,73,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Climate Change Governance,90,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Climate Strategy Impacts,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Climate-Related Management Incentives,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Coverage of Environmental Management Policy,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Direct Greenhouse Gas Emissions (Scope 1),100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,EMS: Certification/ Audit/ Verification,54,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,EP - Biological Oxygen Demand,73,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,EP - Electricity Purchased,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Emissions Reduction Targets,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Energy Use,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Environmental Reporting - Materiality,59,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Environmental Reporting - Quantitative Data,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Financial Opportunities Arising from Climate Change,20,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Financial Risks of Climate Change,20,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Hazardous Waste,31,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 2),90,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 3),83,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Low-Carbon Products,,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,NOx Emissions,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,SOx Emissions,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Volatile Organic Compounds Emissions,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Waste Disposal,69,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Water Use,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Analysis of Risks,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Audit Conflict of Interest,81,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Board Diversity Policy,60,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Board Effectiveness,48,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Board Gender Diversity,4,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,CEO-to-Employee Pay Ratio,0,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Codes of Conduct: Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Compliance to Regulatory Standards,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Corporate Governance Policy,88,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Critical Supplier Identification,98,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Customer Feedback Process,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Customer Satisfaction Measurement,64,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Direct-to-Consumer Marketing,0,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Direct-to-Consumer Marketing: OPDP,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Direct-to-Consumer Marketing: Policies,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Ethical Marketing - Complaints Tracking,85,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Expenses Associated with Product Recalls,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Open Innovation,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Opportunities,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Process Innovations,50,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Product Innovations (Healthcare),50,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Product Recalls (Health Care),90,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,R&D Core or Basic Research,74,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,R&D Development Stages,90,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,R&D Ideation or Applied Research,90,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,R&D Launch,58,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,R&D Post-Launch,70,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,R&D Spending,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Responsibilities and Committees,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Responsibility Risk & Crisis Management,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Risk Response Strategy,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Sales Channels Variety & Innovation,57,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Sales Effectiveness Targets,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Sensitivity Analysis & Stress Testing,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Service Orientation,71,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Supplier Risk Management Measures,70,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Supply Chain Risk Exposure,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Supply Chain Transparency & Reporting,54,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Tax Reporting,50,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Tax Strategy and Governance,0,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Taxation Governance & Risks,25,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Transparency of Executive Compensation,75,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Access to Genetic Resources,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Access to Healthcare Programs (Products),100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Balance of Variable Compensation Based on Corporate and I,70,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Benefits Sharing,75,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Bioethics Policy,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Business and Human Rights,81,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,CEO Compensation - Success Metrics,52,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Contribution to Increasing Healthcare Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Corporate Citizenship Strategy,90,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Coverage of Employees through Predefined Performance Appr,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Employee Development Programs,60,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Employee Support Programs,85,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Employee Turnover Rate,75,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Fair Pricing,92,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Gender Pay Indicators,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,HTA Support of Value Proposition,25,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Health Management,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Healthy Lifestyle Incentive,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Human Capital Performance Indicators,40,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Human Capital Return on Investment,0,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Labor KPIs - Layoffs,50,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,87,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Measure Contribution to Health Outcome,52,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Measuring Benefits,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Network Orientation,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Occupational Illness Frequency Rate (OIFR) - Employees,99,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Partnerships for Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Percentage of Performance Related Compensation for each E,0,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Public Commitment to Human Rights,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Return on Employee Development Investment,25,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Social Reporting - Materiality,35,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Social Reporting - Quantitative Data,42,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Stakeholder Engagement Governance,78,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Stakeholder Engagement Implementation,95,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Stakeholder Engagement Review,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Training & Development Inputs,25,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Trend of Employee Wellbeing,48,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Volume,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Question,Workforce Breakdown: Gender,70,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Dimension,Economic Governance Dimension,82,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Dimension,Environmental Dimension,80,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Dimension,Social Dimension,78,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Climate Strategy,77,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Environmental Policy & Management Systems,82,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Environmental Reporting,85,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Operational Eco-Efficiency,76,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Business Ethics,85,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Corporate Governance,75,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Customer Relationship Management,81,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Innovation Management,75,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Marketing Practices,86,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Product Quality & Recall Management,98,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Risk & Crisis Management,97,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Supply Chain Management,87,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Tax Strategy,44,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Addressing Cost Burden,71,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Bioethics,93,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Corporate Citizenship & Philanthropy,98,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Health Outcome Contribution,83,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Human Capital Development,35,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Labor Practice Indicators,90,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Occupational Health & Safety,97,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Social Reporting,69,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Stakeholder Engagement,92,016101,ABBV,AbbVie Inc.
4558282,2014-09-11,Criteria,Talent Attraction & Retention,69,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,S&P Global ESG Score,S&P Global ESG Score,86,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Chemical Oxygen Demand,70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Climate Change Governance,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Climate Strategy Impacts,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Climate-Related Management Incentives,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Coverage of Environmental Management Policy,44,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Direct Greenhouse Gas Emissions (Scope 1),80,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,EMS: Certification/ Audit/ Verification,67,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,EP - Biological Oxygen Demand,70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,EP - Electricity Purchased,79,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Emissions Reduction Targets,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Energy Use,80,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Environmental Reporting - Materiality,83,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Environmental Reporting - Quantitative Data,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Environmental Violations,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Financial Opportunities Arising from Climate Change,20,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Financial Risks of Climate Change,20,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Hazardous Waste,50,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 3),50,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,NOx Emissions,70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,SOx Emissions,70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Volatile Organic Compounds Emissions,70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Waste Disposal,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Water Use,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Board Diversity Policy,60,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Board Effectiveness,58,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Board Gender Diversity,4,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,CEO Compensation - Success Metrics,58,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,CEO-to-Employee Pay Ratio,78,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Codes of Conduct: Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Compliance to Regulatory Standards,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Critical Supplier Identification,98,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Customer Satisfaction Measurement,97,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Direct-to-Consumer Marketing,0,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Direct-to-Consumer Marketing: OPDP,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Direct-to-Consumer Marketing: Policies,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Ethical Marketing - Complaints Tracking,85,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Expenses Associated with Product Recalls,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Management Ownership Requirements,83,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Open Innovation,65,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Opportunities,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Process Innovations,50,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Product Innovations (Healthcare),65,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Product Recalls (Health Care),70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Quality Management & Audits of Distribution Networks,79,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,R&D Core or Basic Research,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,R&D Development Stages,82,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,R&D Ideation or Applied Research,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,R&D Launch,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,R&D Post-Launch,60,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Responsibilities and Committees,86,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Risk Culture,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Risk Governance,70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Risks Correlation,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Sales Channels Variety & Innovation,79,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Sales Effectiveness Targets,75,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Service Orientation,78,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Supplier Risk Management Measures,75,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Supply Chain Risk Exposure,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Supply Chain Transparency & Reporting,64,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Tax Reporting,50,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Tax Strategy and Governance,50,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Taxation Governance & Risks,75,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Transparency of Executive Compensation,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Access to Genetic Resources,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Access to Healthcare Programs (Products),100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Benefits Sharing,70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Bioethics Policy,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Business and Human Rights,81,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Contribution to Increasing Healthcare Efficiency,70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Corporate Citizenship Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Employee Development Programs,55,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Employee Support Programs,89,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Employee Turnover Rate,62,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Fair Pricing,92,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Gender Pay Indicators,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,HTA Support of Value Proposition,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Health Management,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Healthy Lifestyle Incentive,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Human Capital Performance Indicators,40,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Human Capital Return on Investment,,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Labor KPIs - Layoffs,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Measure Contribution to Health Outcome,93,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Measuring Benefits,50,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Network Orientation,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Occupational Illness Frequency Rate (OIFR) - Employees,99,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Partnerships for Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Public Commitment to Human Rights,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Return on Employee Development Investment,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Social Reporting - Materiality,25,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Social Reporting - Quantitative Data,51,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Stakeholder Engagement Governance,78,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Stakeholder Engagement Implementation,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Stakeholder Engagement Review,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Training & Development Inputs,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Trend of Employee Wellbeing,,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Volume,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Workforce Breakdown: Gender,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Dimension,Economic Governance Dimension,85,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Dimension,Environmental Dimension,82,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Dimension,Social Dimension,89,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Climate Strategy,72,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Environmental Policy & Management Systems,78,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Environmental Reporting,96,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Operational Eco-Efficiency,76,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Business Ethics,85,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Corporate Governance,77,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Customer Relationship Management,87,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Innovation Management,78,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Marketing Practices,87,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Product Quality & Recall Management,94,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Risk & Crisis Management,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Supply Chain Management,91,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Tax Strategy,71,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Addressing Cost Burden,88,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Bioethics,91,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Corporate Citizenship & Philanthropy,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Health Outcome Contribution,97,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Human Capital Development,69,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Labor Practice Indicators,96,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Occupational Health & Safety,98,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Social Reporting,69,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Stakeholder Engagement,91,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Talent Attraction & Retention,91,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,S&P Global ESG Score,S&P Global ESG Score,86,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Chemical Oxygen Demand,70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Climate Change Governance,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Climate Strategy Impacts,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Climate-Related Management Incentives,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Coverage of Environmental Management Policy,44,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Direct Greenhouse Gas Emissions (Scope 1),80,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,EMS: Certification/ Audit/ Verification,67,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,EP - Biological Oxygen Demand,70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,EP - Electricity Purchased,79,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Emissions Reduction Targets,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Energy Use,80,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Environmental Reporting - Materiality,83,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Environmental Reporting - Quantitative Data,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Environmental Violations,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Financial Opportunities Arising from Climate Change,20,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Financial Risks of Climate Change,20,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Hazardous Waste,50,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 3),50,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,NOx Emissions,70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,SOx Emissions,70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Volatile Organic Compounds Emissions,70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Waste Disposal,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Water Use,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Board Diversity Policy,60,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Board Effectiveness,58,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Board Gender Diversity,4,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,CEO Compensation - Success Metrics,58,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,CEO-to-Employee Pay Ratio,0,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Codes of Conduct: Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Compliance to Regulatory Standards,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Critical Supplier Identification,98,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Customer Satisfaction Measurement,97,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Direct-to-Consumer Marketing,0,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Direct-to-Consumer Marketing: OPDP,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Direct-to-Consumer Marketing: Policies,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Ethical Marketing - Complaints Tracking,85,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Expenses Associated with Product Recalls,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Management Ownership Requirements,83,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Open Innovation,65,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Opportunities,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Process Innovations,50,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Product Innovations (Healthcare),65,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Product Recalls (Health Care),70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Quality Management & Audits of Distribution Networks,79,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,R&D Core or Basic Research,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,R&D Development Stages,82,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,R&D Ideation or Applied Research,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,R&D Launch,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,R&D Post-Launch,60,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Responsibilities and Committees,86,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Risk Culture,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Risk Governance,70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Risks Correlation,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Sales Channels Variety & Innovation,79,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Sales Effectiveness Targets,75,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Service Orientation,78,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Supplier Risk Management Measures,75,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Supply Chain Risk Exposure,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Supply Chain Transparency & Reporting,64,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Tax Reporting,50,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Tax Strategy and Governance,50,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Taxation Governance & Risks,75,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Transparency of Executive Compensation,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Access to Genetic Resources,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Access to Healthcare Programs (Products),100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Benefits Sharing,70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Bioethics Policy,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Business and Human Rights,81,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Contribution to Increasing Healthcare Efficiency,70,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Corporate Citizenship Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Employee Development Programs,55,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Employee Support Programs,89,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Employee Turnover Rate,62,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Fair Pricing,92,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Gender Pay Indicators,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,HTA Support of Value Proposition,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Health Management,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Healthy Lifestyle Incentive,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Human Capital Performance Indicators,40,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Human Capital Return on Investment,,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Labor KPIs - Layoffs,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Measure Contribution to Health Outcome,93,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Measuring Benefits,50,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Network Orientation,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Occupational Illness Frequency Rate (OIFR) - Employees,99,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Partnerships for Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Public Commitment to Human Rights,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Return on Employee Development Investment,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Social Reporting - Materiality,25,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Social Reporting - Quantitative Data,51,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Stakeholder Engagement Governance,78,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Stakeholder Engagement Implementation,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Stakeholder Engagement Review,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Training & Development Inputs,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Trend of Employee Wellbeing,,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Volume,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Question,Workforce Breakdown: Gender,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Dimension,Economic Governance Dimension,84,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Dimension,Environmental Dimension,82,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Dimension,Social Dimension,89,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Climate Strategy,72,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Environmental Policy & Management Systems,78,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Environmental Reporting,96,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Operational Eco-Efficiency,76,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Business Ethics,85,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Corporate Governance,73,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Customer Relationship Management,87,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Innovation Management,78,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Marketing Practices,87,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Product Quality & Recall Management,94,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Risk & Crisis Management,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Supply Chain Management,91,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Tax Strategy,71,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Addressing Cost Burden,88,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Bioethics,91,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Corporate Citizenship & Philanthropy,90,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Health Outcome Contribution,97,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Human Capital Development,69,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Labor Practice Indicators,96,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Occupational Health & Safety,98,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Social Reporting,69,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Stakeholder Engagement,91,016101,ABBV,AbbVie Inc.
4558282,2015-09-10,Criteria,Talent Attraction & Retention,91,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,S&P Global ESG Score,S&P Global ESG Score,85,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Climate Change Governance,90,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Climate Strategy Impacts,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Climate-Related Management Incentives,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Coverage of Environmental Management Policy,67,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Direct Greenhouse Gas Emissions (Scope 1),80,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,EMS: Certification/ Audit/ Verification,60,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,EP - Biological Oxygen Demand,70,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Emissions Reduction Targets,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Energy Use,80,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Environmental Reporting - Quantitative Data,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Financial Opportunities Arising from Climate Change,20,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Financial Risks of Climate Change,85,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Hazardous Waste,94,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 3),50,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Waste Disposal,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Water Use,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Board Diversity Policy,70,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Board Effectiveness,58,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Board Gender Diversity,4,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,CEO Compensation - Success Metrics,81,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,CEO-to-Employee Pay Ratio,0,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Codes of Conduct: Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Compliance to Regulatory Standards,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Critical Supplier Identification,98,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Direct-to-Consumer Marketing,58,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Direct-to-Consumer Marketing: OPDP,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Direct-to-Consumer Marketing: Policies,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Expenses Associated with Product Recalls,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Management Ownership Requirements,83,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Material Issues for Enterprise Value Creation,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Materiality Analysis,50,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Open Innovation,90,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Opportunities,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Process Innovations,50,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Product Innovations (Healthcare),65,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Product Recalls (Health Care),96,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,R&D Core or Basic Research,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,R&D Development Stages,92,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,R&D Ideation or Applied Research,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,R&D Launch,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,R&D Post-Launch,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Responsibilities and Committees,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Risk Culture,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Risk Governance,60,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Risks Correlation,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Service Orientation,76,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Supplier Risk Management Measures,81,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Supply Chain Risk Exposure,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Supply Chain Transparency & Reporting,83,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Tax Reporting,50,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Tax Strategy and Governance,0,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Taxation Governance & Risks,90,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Transparency of Executive Compensation,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Access to Medicine Strategy Reporting,54,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Contribution to Increasing Healthcare Efficiency,85,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Corporate Citizenship Strategy,87,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Employee Development Programs,85,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Employee Support Programs,89,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Fair Pricing,92,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Gender Pay Indicators,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Governance,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,HTA Support of Value Proposition,25,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Health Management,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Healthy Lifestyle Incentive,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Human Capital Performance Indicators,40,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Human Capital Return on Investment,70,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Human Rights Assessment,28,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Human Rights Commitment,67,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Human Rights Due Diligence Process,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Human Rights Mitigation & Remediation,20,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Labor KPIs - Layoffs,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Local Capacity Building,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Measure Contribution to Health Outcome,78,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Network Orientation,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Return on Employee Development Investment,0,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Social Reporting - Quantitative Data,60,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Training & Development Inputs,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Trend of Employee Wellbeing,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Workforce Breakdown: Gender,90,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Dimension,Economic Governance Dimension,87,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Dimension,Environmental Dimension,87,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Dimension,Social Dimension,83,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Climate Strategy,80,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Environmental Policy & Management Systems,76,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Environmental Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Operational Eco-Efficiency,89,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Business Ethics,85,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Corporate Governance,76,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Innovation Management,85,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Marketing Practices,94,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Materiality,85,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Product Quality & Recall Management,99,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Risk & Crisis Management,88,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Supply Chain Management,94,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Tax Strategy,60,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Access to Healthcare,78,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Addressing Cost Burden,66,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Corporate Citizenship & Philanthropy,95,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Health Outcome Contribution,92,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Human Capital Development,58,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Labor Practice Indicators,78,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Occupational Health & Safety,99,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Social Reporting,87,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Talent Attraction & Retention,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,S&P Global ESG Score,S&P Global ESG Score,85,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Climate Change Governance,90,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Climate Strategy Impacts,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Climate-Related Management Incentives,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Coverage of Environmental Management Policy,67,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Direct Greenhouse Gas Emissions (Scope 1),80,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,EMS: Certification/ Audit/ Verification,60,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,EP - Biological Oxygen Demand,70,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Emissions Reduction Targets,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Energy Use,80,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Environmental Reporting - Quantitative Data,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Financial Opportunities Arising from Climate Change,20,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Financial Risks of Climate Change,85,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Hazardous Waste,94,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 3),50,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Waste Disposal,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Water Use,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Board Diversity Policy,70,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Board Effectiveness,58,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Board Gender Diversity,4,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,CEO Compensation - Success Metrics,81,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,CEO-to-Employee Pay Ratio,0,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Codes of Conduct: Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Compliance to Regulatory Standards,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Critical Supplier Identification,98,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Direct-to-Consumer Marketing,58,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Direct-to-Consumer Marketing: OPDP,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Direct-to-Consumer Marketing: Policies,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Expenses Associated with Product Recalls,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Management Ownership Requirements,83,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Material Issues for Enterprise Value Creation,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Materiality Analysis,50,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Open Innovation,90,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Opportunities,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Process Innovations,50,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Product Innovations (Healthcare),65,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Product Recalls (Health Care),96,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,R&D Core or Basic Research,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,R&D Development Stages,92,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,R&D Ideation or Applied Research,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,R&D Launch,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,R&D Post-Launch,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Responsibilities and Committees,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Risk Culture,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Risk Governance,60,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Risks Correlation,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Service Orientation,76,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Supplier Risk Management Measures,81,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Supply Chain Risk Exposure,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Supply Chain Transparency & Reporting,83,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Tax Reporting,50,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Tax Strategy and Governance,0,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Taxation Governance & Risks,90,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Transparency of Executive Compensation,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Access to Medicine Strategy Reporting,54,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Contribution to Increasing Healthcare Efficiency,85,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Corporate Citizenship Strategy,87,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Employee Development Programs,85,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Employee Support Programs,89,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Fair Pricing,92,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Gender Pay Indicators,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Governance,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,HTA Support of Value Proposition,25,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Health Management,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Healthy Lifestyle Incentive,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Human Capital Performance Indicators,40,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Human Capital Return on Investment,70,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Human Rights Assessment,28,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Human Rights Commitment,67,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Human Rights Due Diligence Process,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Human Rights Mitigation & Remediation,20,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Labor KPIs - Layoffs,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Local Capacity Building,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Measure Contribution to Health Outcome,78,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Network Orientation,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Return on Employee Development Investment,0,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Social Reporting - Quantitative Data,60,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Training & Development Inputs,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Trend of Employee Wellbeing,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Question,Workforce Breakdown: Gender,90,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Dimension,Economic Governance Dimension,87,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Dimension,Environmental Dimension,87,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Dimension,Social Dimension,83,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Climate Strategy,80,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Environmental Policy & Management Systems,76,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Environmental Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Operational Eco-Efficiency,89,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Business Ethics,85,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Corporate Governance,76,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Innovation Management,85,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Marketing Practices,94,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Materiality,85,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Product Quality & Recall Management,99,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Risk & Crisis Management,88,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Supply Chain Management,94,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Tax Strategy,60,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Access to Healthcare,78,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Addressing Cost Burden,66,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Corporate Citizenship & Philanthropy,95,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Health Outcome Contribution,92,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Human Capital Development,58,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Labor Practice Indicators,78,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Occupational Health & Safety,99,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Social Reporting,87,016101,ABBV,AbbVie Inc.
4558282,2016-09-08,Criteria,Talent Attraction & Retention,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,S&P Global ESG Score,S&P Global ESG Score,85,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Climate Strategy - CDP Alignment,,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Climate-Related Management Incentives,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Coverage of Environmental Management Policy,67,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Direct Greenhouse Gas Emissions (Scope 1),100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,EMS: Certification/ Audit/ Verification,60,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,EP - Biological Oxygen Demand,10,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Emissions Reduction Targets,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Energy Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Environmental Reporting - Quantitative Data,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Financial Opportunities Arising from Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Financial Risks of Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Hazardous Waste,80,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 3),33,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Waste Disposal,80,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Water Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Anti-Competitive Practices,58,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Board Average Tenure,36,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Board Diversity Policy,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Board Effectiveness,50,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Board Gender Diversity,33,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Board Industry Experience,11,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,CEO Compensation - Success Metrics,67,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,CEO-to-Employee Pay Ratio,0,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Codes of Conduct: Coverage,67,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Compliance to Regulatory Standards,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Contributions & Other Spending,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Corruption & Bribery Cases,80,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Critical Supplier Identification,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Direct-to-Consumer Marketing,76,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Direct-to-Consumer Marketing: OPDP,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Direct-to-Consumer Marketing: Policies,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Expenses Associated with Product Recalls,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Impact Valuation,30,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Largest Contributions & Expenditures,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Management Ownership Requirements,83,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Material Issues for Enterprise Value Creation,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Materiality Analysis,50,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Open Innovation,90,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Process Innovations,20,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Product Innovations (Healthcare),55,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Product Recalls (Health Care),96,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,R&D Core or Basic Research,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,R&D Development Stages,92,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,R&D Ideation or Applied Research,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,R&D Launch,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,R&D Spending,,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Responsibilities and Committees,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Risk Culture,84,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Risk Governance,60,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Risks Correlation,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Supplier Code of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Supplier Risk Management Measures,35,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Supply Chain Risk Exposure,88,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Supply Chain Transparency & Reporting,76,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Tax Reporting,50,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Tax Strategy and Governance,0,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Taxation Governance & Risks,90,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Valuation Disclosure,50,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Access to Medicine Strategy Reporting,48,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Contribution to Increasing Healthcare Efficiency,85,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Corporate Citizenship Strategy,90,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Employee Development Programs,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Employee Support Programs,80,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Fair Pricing,92,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Gender Pay Indicators,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Governance,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,HTA Support of Value Proposition,50,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Healthy Lifestyle Incentive,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Human Capital Return on Investment,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Human Rights Assessment,65,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Human Rights Commitment,60,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Human Rights Due Diligence Process,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Human Rights Mitigation & Remediation,60,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Local Capacity Building,83,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Long-Term Incentives for Employees,95,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Measure Contribution to Health Outcome,93,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Network Orientation,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Return on Employee Development Investment,0,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Social Reporting - Quantitative Data,60,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Training & Development Inputs,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Trend of Employee Wellbeing,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Workforce Breakdown: Gender,90,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Dimension,Economic Governance Dimension,84,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Dimension,Environmental Dimension,87,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Dimension,Social Dimension,87,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Climate Strategy,90,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Environmental Policy & Management Systems,76,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Environmental Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Operational Eco-Efficiency,85,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Business Ethics,87,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Corporate Governance,70,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Impact Measurement & Valuation,38,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Innovation Management,78,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Marketing Practices,96,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Materiality,85,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Policy Influence,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Product Quality & Recall Management,99,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Risk & Crisis Management,85,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Supply Chain Management,86,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Tax Strategy,60,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Access to Healthcare,71,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Addressing Cost Burden,75,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Corporate Citizenship & Philanthropy,95,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Health Outcome Contribution,97,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Human Capital Development,75,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Human Rights,77,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Labor Practice Indicators,98,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Occupational Health & Safety,97,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Social Reporting,87,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Talent Attraction & Retention,99,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,S&P Global ESG Score,S&P Global ESG Score,85,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Climate Strategy - CDP Alignment,,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Climate-Related Management Incentives,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Coverage of Environmental Management Policy,67,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Direct Greenhouse Gas Emissions (Scope 1),100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,EMS: Certification/ Audit/ Verification,60,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,EP - Biological Oxygen Demand,10,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Emissions Reduction Targets,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Energy Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Environmental Reporting - Quantitative Data,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Financial Opportunities Arising from Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Financial Risks of Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Hazardous Waste,80,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 3),33,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Waste Disposal,80,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Water Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Anti-Competitive Practices,0,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Board Average Tenure,36,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Board Diversity Policy,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Board Effectiveness,50,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Board Gender Diversity,33,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Board Industry Experience,11,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,CEO Compensation - Success Metrics,67,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,CEO-to-Employee Pay Ratio,0,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Codes of Conduct: Coverage,67,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Compliance to Regulatory Standards,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Contributions & Other Spending,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Corruption & Bribery Cases,80,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Critical Supplier Identification,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Direct-to-Consumer Marketing,76,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Direct-to-Consumer Marketing: OPDP,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Direct-to-Consumer Marketing: Policies,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Expenses Associated with Product Recalls,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Impact Valuation,30,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Largest Contributions & Expenditures,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Management Ownership Requirements,83,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Material Issues for Enterprise Value Creation,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Materiality Analysis,50,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Open Innovation,90,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Process Innovations,20,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Product Innovations (Healthcare),55,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Product Recalls (Health Care),96,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,R&D Core or Basic Research,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,R&D Development Stages,92,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,R&D Ideation or Applied Research,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,R&D Launch,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,R&D Spending,,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Responsibilities and Committees,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Risk Culture,84,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Risk Governance,60,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Risks Correlation,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Supplier Code of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Supplier Risk Management Measures,35,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Supply Chain Risk Exposure,88,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Supply Chain Transparency & Reporting,76,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Tax Reporting,50,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Tax Strategy and Governance,0,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Taxation Governance & Risks,90,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Valuation Disclosure,50,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Access to Medicine Strategy Reporting,48,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Contribution to Increasing Healthcare Efficiency,85,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Corporate Citizenship Strategy,90,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Employee Development Programs,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Employee Support Programs,80,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Fair Pricing,92,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Gender Pay Indicators,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Governance,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,HTA Support of Value Proposition,50,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Healthy Lifestyle Incentive,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Human Capital Return on Investment,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Human Rights Assessment,65,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Human Rights Commitment,60,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Human Rights Due Diligence Process,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Human Rights Mitigation & Remediation,60,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Local Capacity Building,83,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Long-Term Incentives for Employees,95,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Measure Contribution to Health Outcome,93,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Network Orientation,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Return on Employee Development Investment,0,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Social Reporting - Quantitative Data,60,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Training & Development Inputs,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Trend of Employee Wellbeing,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Question,Workforce Breakdown: Gender,90,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Dimension,Economic Governance Dimension,83,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Dimension,Environmental Dimension,87,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Dimension,Social Dimension,87,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Climate Strategy,90,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Environmental Policy & Management Systems,76,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Environmental Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Operational Eco-Efficiency,85,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Business Ethics,81,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Corporate Governance,70,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Impact Measurement & Valuation,38,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Innovation Management,78,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Marketing Practices,96,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Materiality,85,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Policy Influence,100,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Product Quality & Recall Management,99,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Risk & Crisis Management,85,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Supply Chain Management,86,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Tax Strategy,60,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Access to Healthcare,71,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Addressing Cost Burden,75,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Corporate Citizenship & Philanthropy,95,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Health Outcome Contribution,97,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Human Capital Development,75,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Human Rights,77,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Labor Practice Indicators,98,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Occupational Health & Safety,97,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Social Reporting,87,016101,ABBV,AbbVie Inc.
4558282,2017-09-07,Criteria,Talent Attraction & Retention,99,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,S&P Global ESG Score,S&P Global ESG Score,80,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Climate Strategy - CDP Alignment,,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Climate-Related Management Incentives,70,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Coverage of Environmental Management Policy,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),90,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,EMS: Certification/ Audit/ Verification,75,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,EP - Biological Oxygen Demand,70,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Emissions Reduction Targets,80,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Energy Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Environmental Reporting - Quantitative Data,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Financial Opportunities Arising from Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Financial Risks of Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Hazardous Waste,80,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Waste Disposal,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Water Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Anti-Competitive Practices,80,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Board Average Tenure,44,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Board Diversity Policy,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Board Effectiveness,58,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Board Gender Diversity,58,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Board Industry Experience,10,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,CEO Compensation - Long-Term Performance Alignment,38,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,CEO Compensation - Success Metrics,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,CEO-to-Employee Pay Ratio,30,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Codes of Conduct: Coverage,67,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Compliance to Regulatory Standards,93,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Contributions & Other Spending,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Corruption & Bribery Cases,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Critical Supplier Identification,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Direct-to-Consumer Marketing,41,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Dual Class Shares,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Effective Tax Rate,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Family Ownership,0,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Government Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Largest Contributions & Expenditures,44,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Management Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Management Ownership Requirements,60,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Material Issues for Enterprise Value Creation,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Materiality Analysis,75,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Open Innovation,90,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Process Innovations,50,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Product Innovations (Healthcare),65,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Product Recalls (Health Care),96,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,R&D Core or Basic Research,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,R&D Development Stages,82,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,R&D Ideation or Applied Research,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,R&D Launch,90,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,R&D Spending,,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Risk Culture,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Risk Governance,60,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Supplier Code of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Supplier Risk Management Measures,30,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Supply Chain Risk Exposure,84,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Supply Chain Transparency & Reporting,70,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Tax Reporting,50,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Tax Strategy and Governance,0,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Access to Medicine Strategy Reporting,40,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Contribution to Increasing Healthcare Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Corporate Citizenship Strategy,87,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Employee Development Programs,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Employee Support Programs,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Fair Pricing,40,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Gender Pay Indicators,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,HTA Support of Value Proposition,50,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Human Capital Return on Investment,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Human Rights Assessment,68,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Human Rights Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Human Rights Due Diligence Process,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Human Rights Mitigation & Remediation,50,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Local Capacity Building,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Measure Contribution to Health Outcome,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,80,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Return on Employee Development Investment,0,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Social Reporting - Quantitative Data,67,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Training & Development Inputs,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Trend of Employee Wellbeing,92,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Workforce Breakdown: Gender,90,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Dimension,Economic Governance Dimension,73,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Dimension,Environmental Dimension,92,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Dimension,Social Dimension,85,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Climate Strategy,92,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Environmental Policy & Management Systems,86,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Environmental Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Operational Eco-Efficiency,92,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Business Ethics,61,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Corporate Governance,68,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Innovation Management,81,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Marketing Practices,84,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Materiality,93,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Policy Influence,79,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Product Quality & Recall Management,72,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Risk & Crisis Management,76,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Supply Chain Management,79,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Tax Strategy,36,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Access to Healthcare,67,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Addressing Cost Burden,62,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Corporate Citizenship & Philanthropy,94,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Health Outcome Contribution,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Human Capital Development,75,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Human Rights,80,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Labor Practice Indicators,97,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Occupational Health & Safety,95,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Social Reporting,89,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Talent Attraction & Retention,98,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,S&P Global ESG Score,S&P Global ESG Score,80,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Climate Strategy - CDP Alignment,,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Climate-Related Management Incentives,70,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Coverage of Environmental Management Policy,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),90,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,EMS: Certification/ Audit/ Verification,75,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,EP - Biological Oxygen Demand,70,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Emissions Reduction Targets,80,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Energy Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Environmental Reporting - Quantitative Data,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Financial Opportunities Arising from Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Financial Risks of Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Hazardous Waste,80,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Waste Disposal,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Water Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Anti-Competitive Practices,80,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Board Average Tenure,44,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Board Diversity Policy,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Board Effectiveness,58,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Board Gender Diversity,58,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Board Industry Experience,10,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,CEO Compensation - Long-Term Performance Alignment,38,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,CEO Compensation - Success Metrics,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,CEO-to-Employee Pay Ratio,30,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Codes of Conduct: Coverage,67,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Compliance to Regulatory Standards,93,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Contributions & Other Spending,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Corruption & Bribery Cases,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Critical Supplier Identification,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Direct-to-Consumer Marketing,41,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Dual Class Shares,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Effective Tax Rate,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Family Ownership,0,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Government Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Largest Contributions & Expenditures,44,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Management Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Management Ownership Requirements,60,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Material Issues for Enterprise Value Creation,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Materiality Analysis,75,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Open Innovation,90,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Process Innovations,50,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Product Innovations (Healthcare),65,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Product Recalls (Health Care),96,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,R&D Core or Basic Research,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,R&D Development Stages,82,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,R&D Ideation or Applied Research,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,R&D Launch,90,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,R&D Spending,,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Risk Culture,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Risk Governance,60,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Supplier Code of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Supplier Risk Management Measures,30,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Supply Chain Risk Exposure,84,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Supply Chain Transparency & Reporting,70,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Tax Reporting,50,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Tax Strategy and Governance,0,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Access to Medicine Strategy Reporting,40,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Contribution to Increasing Healthcare Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Corporate Citizenship Strategy,87,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Employee Development Programs,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Employee Support Programs,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Fair Pricing,40,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Gender Pay Indicators,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,HTA Support of Value Proposition,50,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Human Capital Return on Investment,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Human Rights Assessment,68,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Human Rights Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Human Rights Due Diligence Process,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Human Rights Mitigation & Remediation,50,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Local Capacity Building,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Measure Contribution to Health Outcome,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,80,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Return on Employee Development Investment,0,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Social Reporting - Quantitative Data,67,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Training & Development Inputs,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Trend of Employee Wellbeing,92,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Question,Workforce Breakdown: Gender,90,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Dimension,Economic Governance Dimension,73,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Dimension,Environmental Dimension,92,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Dimension,Social Dimension,85,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Climate Strategy,92,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Environmental Policy & Management Systems,86,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Environmental Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Operational Eco-Efficiency,92,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Business Ethics,61,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Corporate Governance,68,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Innovation Management,81,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Marketing Practices,84,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Materiality,93,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Policy Influence,79,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Product Quality & Recall Management,72,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Risk & Crisis Management,76,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Supply Chain Management,79,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Tax Strategy,36,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Access to Healthcare,67,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Addressing Cost Burden,62,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Corporate Citizenship & Philanthropy,94,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Health Outcome Contribution,100,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Human Capital Development,75,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Human Rights,80,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Labor Practice Indicators,97,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Occupational Health & Safety,95,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Social Reporting,89,016101,ABBV,AbbVie Inc.
4558282,2018-09-13,Criteria,Talent Attraction & Retention,98,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,S&P Global ESG Score,S&P Global ESG Score,76,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Climate-Related Management Incentives,70,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Coverage of Environmental Management Policy,80,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),90,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,EMS: Certification/ Audit/ Verification,82,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Emissions Reduction Targets,80,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Energy Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Environmental Reporting - Quantitative Data,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Financial Opportunities Arising from Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Financial Risks of Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Hazardous Waste,80,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Waste Disposal,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Water Consumption,90,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Anti-Competitive Practices,80,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Board Average Tenure,62,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Board Diversity Policy,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Board Effectiveness,70,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Board Gender Diversity,58,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Board Industry Experience,17,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,CEO Compensation - Long-Term Performance Alignment,38,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,CEO Compensation - Success Metrics,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,CEO-to-Employee Pay Ratio,30,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Codes of Conduct: Coverage,89,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Compliance to Regulatory Standards,94,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Contributions & Other Spending,67,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Corruption & Bribery Cases,80,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Critical Supplier Identification,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Direct-to-Consumer Marketing,52,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Dual Class Shares,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Effective Tax Rate,30,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Family Ownership,,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Government Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Largest Contributions & Expenditures,68,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Management Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Management Ownership Requirements,60,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Material Issues for Enterprise Value Creation,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Materiality Analysis,75,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Open Innovation,85,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Process Innovations,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Product Innovations (Healthcare),80,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Product Recalls (Health Care),95,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,R&D Core or Basic Research,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,R&D Development Stages,92,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,R&D Ideation or Applied Research,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,R&D Launch,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,R&D Spending,,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Risk Culture,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Risk Governance,70,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Supplier Code of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Supplier Risk Management Measures,10,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Supply Chain Risk Exposure,88,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Supply Chain Transparency & Reporting,67,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Tax Reporting,50,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Tax Strategy and Governance,0,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Access to Medicine Strategy Reporting,54,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Contribution to Increasing Healthcare Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Corporate Citizenship Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Employee Development Programs,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Employee Support Programs,75,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Fair Pricing,60,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Gender Pay Indicators,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,HTA Support of Value Proposition,75,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Human Capital Return on Investment,60,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Human Rights Assessment,58,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Human Rights Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Human Rights Due Diligence Process,40,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Human Rights Mitigation & Remediation,0,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Local Capacity Building,83,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Measure Contribution to Health Outcome,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,80,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Return on Employee Development Investment,0,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Social Reporting - Quantitative Data,84,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Training & Development Inputs,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Trend of Employee Wellbeing,95,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Workforce Breakdown: Gender,77,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Dimension,Economic Governance Dimension,67,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Dimension,Environmental Dimension,92,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Dimension,Social Dimension,84,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Climate Strategy,92,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Environmental Policy & Management Systems,81,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Environmental Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Operational Eco-Efficiency,94,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Business Ethics,28,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Corporate Governance,73,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Innovation Management,93,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Marketing Practices,28,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Materiality,93,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Policy Influence,67,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Product Quality & Recall Management,95,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Risk & Crisis Management,79,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Supply Chain Management,76,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Tax Strategy,21,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Access to Healthcare,66,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Addressing Cost Burden,77,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Corporate Citizenship & Philanthropy,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Health Outcome Contribution,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Human Capital Development,67,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Human Rights,50,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Labor Practice Indicators,92,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Occupational Health & Safety,89,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Social Reporting,95,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Talent Attraction & Retention,99,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,S&P Global ESG Score,S&P Global ESG Score,76,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Climate-Related Management Incentives,70,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Coverage of Environmental Management Policy,80,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),90,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,EMS: Certification/ Audit/ Verification,82,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Emissions Reduction Targets,80,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Energy Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Environmental Reporting - Quantitative Data,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Financial Opportunities Arising from Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Financial Risks of Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Hazardous Waste,80,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Waste Disposal,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Water Consumption,90,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Anti-Competitive Practices,80,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Anti-Competitive Practices,80,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Board Average Tenure,62,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Board Diversity Policy,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Board Effectiveness,70,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Board Gender Diversity,58,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Board Industry Experience,17,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,CEO Compensation - Long-Term Performance Alignment,38,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,CEO Compensation - Success Metrics,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,CEO-to-Employee Pay Ratio,30,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Codes of Conduct: Coverage,89,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Codes of Conduct: Coverage,89,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Compliance to Regulatory Standards,94,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Contributions & Other Spending,67,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Corruption & Bribery Cases,80,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Corruption & Bribery Cases,80,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Critical Supplier Identification,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Direct-to-Consumer Marketing,52,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Direct-to-Consumer Marketing,52,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Dual Class Shares,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Effective Tax Rate,30,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Family Ownership,,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Government Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Largest Contributions & Expenditures,68,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Management Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Management Ownership Requirements,60,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Material Issues for Enterprise Value Creation,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Materiality Analysis,75,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Open Innovation,85,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Process Innovations,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Product Innovations (Healthcare),80,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Product Recalls (Health Care),95,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,R&D Core or Basic Research,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,R&D Development Stages,92,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,R&D Ideation or Applied Research,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,R&D Launch,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,R&D Spending,,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Risk Culture,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Risk Governance,70,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Supplier Code of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Supplier Risk Management Measures,10,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Supply Chain Risk Exposure,88,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Supply Chain Transparency & Reporting,67,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Tax Reporting,50,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Tax Strategy and Governance,0,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Access to Medicine Strategy Reporting,54,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Contribution to Increasing Healthcare Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Corporate Citizenship Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Employee Development Programs,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Employee Support Programs,75,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Fair Pricing,60,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Gender Pay Indicators,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,HTA Support of Value Proposition,75,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Human Capital Return on Investment,60,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Human Rights Assessment,58,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Human Rights Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Human Rights Due Diligence Process,40,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Human Rights Mitigation & Remediation,0,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Local Capacity Building,83,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Measure Contribution to Health Outcome,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,80,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Return on Employee Development Investment,0,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Social Reporting - Quantitative Data,84,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Training & Development Inputs,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Trend of Employee Wellbeing,95,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Question,Workforce Breakdown: Gender,77,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Dimension,Economic Governance Dimension,67,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Dimension,Environmental Dimension,92,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Dimension,Social Dimension,84,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Climate Strategy,92,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Environmental Policy & Management Systems,81,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Environmental Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Operational Eco-Efficiency,94,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Business Ethics,28,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Business Ethics,28,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Corporate Governance,73,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Innovation Management,93,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Marketing Practices,28,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Marketing Practices,28,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Materiality,93,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Policy Influence,67,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Product Quality & Recall Management,95,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Risk & Crisis Management,79,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Supply Chain Management,76,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Tax Strategy,21,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Access to Healthcare,66,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Addressing Cost Burden,77,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Corporate Citizenship & Philanthropy,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Health Outcome Contribution,100,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Human Capital Development,67,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Human Rights,50,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Labor Practice Indicators,92,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Occupational Health & Safety,89,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Social Reporting,95,016101,ABBV,AbbVie Inc.
4558282,2019-09-13,Criteria,Talent Attraction & Retention,99,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,S&P Global ESG Score,S&P Global ESG Score,81,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Climate-Related Management Incentives,70,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Coverage of Environmental Management Policy,80,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Direct Greenhouse Gas Emissions (Scope 1),90,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,EMS: Certification/ Audit/ Verification,75,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Emissions Reduction Targets,80,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Energy Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Financial Opportunities Arising from Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Financial Risks of Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Hazardous Waste,60,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Waste Disposal,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Water Consumption,90,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Anti-Competitive Practices,50,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Board Average Tenure,73,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Board Diversity Policy,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Board Effectiveness,70,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Board Gender Diversity,50,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Board Industry Experience,30,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Board Type,82,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,CEO Compensation - Long-Term Performance Alignment,38,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,CEO Compensation - Success Metrics,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,CEO-to-Employee Pay Ratio,30,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Codes of Conduct: Coverage,89,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Compliance to Regulatory Standards,94,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Contributions & Other Spending,50,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Corruption & Bribery Cases,80,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Critical Supplier Identification,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Direct-to-Consumer Marketing,0,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Dual Class Shares,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Effective Tax Rate,0,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Family Ownership,,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Government Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,IT Security/ Cybersecurity Governance,50,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,IT Security/ Cybersecurity Measures,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,IT Security/ Cybersecurity Process & Infrastructure,35,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Largest Contributions & Expenditures,56,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Management Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Management Ownership Requirements,60,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Material Issues for Enterprise Value Creation,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Materiality Analysis,75,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Open Innovation,62,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Process Innovations,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Product Innovations (Healthcare),80,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Product Recalls (Health Care),97,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,R&D Spending,,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,R&D breakout by Innovation Phase,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Risk Culture,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Risk Governance,80,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Supplier Code of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Supplier Risk Management Measures,10,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Supply Chain Risk Exposure,88,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Supply Chain Transparency & Reporting,67,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Tax Reporting,0,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Tax Strategy and Governance,0,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Access to Medicine Strategy Reporting,36,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Contribution to Increasing Healthcare Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Corporate Citizenship Strategy,95,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Employee Development Programs,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Employee Support Programs,75,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Fair Pricing,79,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Freedom of Association,50,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Gender Pay Indicators,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,HTA Support of Value Proposition,75,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Human Capital Return on Investment,92,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Human Rights Assessment,58,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Human Rights Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Human Rights Due Diligence Process,40,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Human Rights Mitigation & Remediation,0,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Local Capacity Building,90,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Measure Contribution to Health Outcome,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Return on Employee Development Investment,0,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Training & Development Inputs,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Trend of Employee Wellbeing,91,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Question,Workforce Breakdown: Gender,76,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Dimension,Economic Governance Dimension,76,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Dimension,Environmental Dimension,90,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Dimension,Social Dimension,84,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Climate Strategy,92,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Environmental Policy & Management Systems,77,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Environmental Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Operational Eco-Efficiency,91,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Business Ethics,81,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Corporate Governance,71,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Information Security/ Cybersecurity & System Availability,57,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Innovation Management,89,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Marketing Practices,73,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Materiality,93,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Policy Influence,52,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Product Quality & Recall Management,95,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Risk & Crisis Management,82,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Supply Chain Management,76,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Tax Strategy,0,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Access to Healthcare,62,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Addressing Cost Burden,84,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Corporate Citizenship & Philanthropy,98,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Health Outcome Contribution,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Human Capital Development,73,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Human Rights,50,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Labor Practice Indicators,77,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Occupational Health & Safety,94,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Social Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2020-11-13,Criteria,Talent Attraction & Retention,98,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,S&P Global ESG Score,S&P Global ESG Score,81,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Climate-Related Management Incentives,70,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Coverage of Environmental Management Policy,80,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Direct Greenhouse Gas Emissions (Scope 1),90,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,EMS: Certification/ Audit/ Verification,75,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Emissions Reduction Targets,80,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Energy Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Financial Opportunities Arising from Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Financial Risks of Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Hazardous Waste,60,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Waste Disposal,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Water Consumption,90,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Anti-Competitive Practices,50,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Board Average Tenure,73,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Board Diversity Policy,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Board Effectiveness,70,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Board Gender Diversity,50,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Board Industry Experience,30,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Board Type,82,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,CEO Compensation - Long-Term Performance Alignment,38,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,CEO Compensation - Success Metrics,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,CEO-to-Employee Pay Ratio,30,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Codes of Conduct: Coverage,89,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Compliance to Regulatory Standards,94,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Contributions & Other Spending,50,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Corruption & Bribery Cases,80,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Critical Supplier Identification,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Direct-to-Consumer Marketing,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Dual Class Shares,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Effective Tax Rate,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Family Ownership,,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Government Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,IT Security/ Cybersecurity Governance,50,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,IT Security/ Cybersecurity Measures,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,IT Security/ Cybersecurity Process & Infrastructure,35,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Largest Contributions & Expenditures,56,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Management Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Management Ownership Requirements,60,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Material Issues for Enterprise Value Creation,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Materiality Analysis,75,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Open Innovation,62,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Process Innovations,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Product Innovations (Healthcare),80,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Product Recalls (Health Care),97,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,R&D Spending,,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,R&D breakout by Innovation Phase,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Risk Culture,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Risk Governance,80,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Supplier Code of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Supplier Risk Management Measures,10,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Supply Chain Risk Exposure,88,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Supply Chain Transparency & Reporting,67,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Tax Reporting,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Tax Strategy and Governance,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Access to Medicine Strategy Reporting,36,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Contribution to Increasing Healthcare Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Corporate Citizenship Strategy,95,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Employee Development Programs,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Employee Support Programs,75,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Fair Pricing,79,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Freedom of Association,50,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Gender Pay Indicators,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,HTA Support of Value Proposition,75,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Human Capital Return on Investment,92,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Human Rights Assessment,58,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Human Rights Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Human Rights Due Diligence Process,40,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Human Rights Mitigation & Remediation,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Local Capacity Building,90,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Measure Contribution to Health Outcome,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Return on Employee Development Investment,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Training & Development Inputs,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Trend of Employee Wellbeing,91,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Workforce Breakdown: Gender,76,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Dimension,Economic Governance Dimension,76,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Dimension,Environmental Dimension,90,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Dimension,Social Dimension,84,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Climate Strategy,92,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Environmental Policy & Management Systems,77,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Environmental Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Operational Eco-Efficiency,91,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Business Ethics,81,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Corporate Governance,71,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Information Security/ Cybersecurity & System Availability,57,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Innovation Management,89,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Marketing Practices,73,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Materiality,93,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Policy Influence,52,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Product Quality & Recall Management,95,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Risk & Crisis Management,82,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Supply Chain Management,76,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Tax Strategy,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Access to Healthcare,62,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Addressing Cost Burden,84,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Corporate Citizenship & Philanthropy,98,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Health Outcome Contribution,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Human Capital Development,73,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Human Rights,50,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Labor Practice Indicators,77,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Occupational Health & Safety,94,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Social Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Talent Attraction & Retention,98,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,S&P Global ESG Score,S&P Global ESG Score,81,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Climate-Related Management Incentives,70,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Coverage of Environmental Management Policy,80,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Direct Greenhouse Gas Emissions (Scope 1),90,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,EMS: Certification/ Audit/ Verification,75,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Emissions Reduction Targets,80,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Energy Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Financial Opportunities Arising from Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Financial Risks of Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Hazardous Waste,60,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Waste Disposal,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Water Consumption,90,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Anti-Competitive Practices,50,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Board Average Tenure,73,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Board Diversity Policy,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Board Effectiveness,70,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Board Gender Diversity,50,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Board Industry Experience,30,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Board Type,82,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,CEO Compensation - Long-Term Performance Alignment,38,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,CEO Compensation - Success Metrics,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,CEO-to-Employee Pay Ratio,30,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Codes of Conduct: Coverage,89,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Compliance to Regulatory Standards,94,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Contributions & Other Spending,50,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Corruption & Bribery Cases,80,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Critical Supplier Identification,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Direct-to-Consumer Marketing,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Dual Class Shares,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Effective Tax Rate,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Family Ownership,,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Government Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,IT Security/ Cybersecurity Governance,50,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,IT Security/ Cybersecurity Measures,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,IT Security/ Cybersecurity Process & Infrastructure,35,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Largest Contributions & Expenditures,56,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Management Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Management Ownership Requirements,60,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Material Issues for Enterprise Value Creation,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Materiality Analysis,75,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Open Innovation,62,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Process Innovations,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Product Innovations (Healthcare),80,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Product Recalls (Health Care),97,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,R&D Spending,,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,R&D breakout by Innovation Phase,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Risk Culture,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Risk Governance,80,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Supplier Code of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Supplier Risk Management Measures,10,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Supply Chain Risk Exposure,88,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Supply Chain Transparency & Reporting,67,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Tax Reporting,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Tax Strategy and Governance,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Access to Medicine Strategy Reporting,36,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Contribution to Increasing Healthcare Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Corporate Citizenship Strategy,95,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Employee Development Programs,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Employee Support Programs,75,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Fair Pricing,79,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Fatalities,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Freedom of Association,50,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Gender Pay Indicators,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,HTA Support of Value Proposition,75,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Human Capital Return on Investment,92,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Human Rights Assessment,58,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Human Rights Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Human Rights Due Diligence Process,40,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Human Rights Mitigation & Remediation,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Local Capacity Building,90,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Measure Contribution to Health Outcome,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Philanthropic Contributions,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Return on Employee Development Investment,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Training & Development Inputs,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Trend of Employee Wellbeing,91,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Question,Workforce Breakdown: Gender,76,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Dimension,Economic Governance Dimension,76,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Dimension,Environmental Dimension,90,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Dimension,Social Dimension,84,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Climate Strategy,92,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Environmental Policy & Management Systems,77,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Environmental Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Operational Eco-Efficiency,91,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Business Ethics,81,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Corporate Governance,71,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Information Security/ Cybersecurity & System Availability,57,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Innovation Management,89,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Marketing Practices,73,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Materiality,93,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Policy Influence,52,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Product Quality & Recall Management,95,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Risk & Crisis Management,82,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Supply Chain Management,76,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Tax Strategy,0,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Access to Healthcare,62,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Addressing Cost Burden,84,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Corporate Citizenship & Philanthropy,98,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Health Outcome Contribution,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Human Capital Development,73,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Human Rights,50,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Labor Practice Indicators,77,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Occupational Health & Safety,94,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Social Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2020-12-18,Criteria,Talent Attraction & Retention,98,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,S&P Global ESG Score,S&P Global ESG Score,82,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Climate Risk Assessment - Transition Risks,15,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Climate-Related Management Incentives,70,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Climate-Related Scenario Analysis,80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Coverage of Environmental Management Policy,80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Direct Greenhouse Gas Emissions (Scope 1),100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,EMS: Certification/ Audit/ Verification,75,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Emissions Reduction Targets,80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Energy Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Financial Opportunities Arising from Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Financial Risks of Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Hazardous Waste,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Physical Climate Risk Adaptation,81,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,TCFD Disclosure,0,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Waste Disposal,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Water Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Anti-Competitive Practices,80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Board Average Tenure,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Board Diversity Policy,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Board Effectiveness,58,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Board Gender Diversity,50,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Board Industry Experience,30,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Board Type,95,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,CEO Compensation - Long-Term Performance Alignment,38,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,CEO Compensation - Success Metrics,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,CEO-to-Employee Pay Ratio,30,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Codes of Conduct: Coverage,89,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Compliance to Regulatory Standards,92,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Contributions & Other Spending,83,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Corruption & Bribery Cases,80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Critical Supplier Identification,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Direct-to-Consumer Marketing,0,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Dual Class Shares,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Effective Tax Rate,0,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Family Ownership,,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Government Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,IT Security/ Cybersecurity Governance,56,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,IT Security/ Cybersecurity Measures,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,IT Security/ Cybersecurity Process & Infrastructure,35,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Largest Contributions & Expenditures,44,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Management Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Management Ownership Requirements,60,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Material Issues for Enterprise Value Creation,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Materiality Analysis,75,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Open Innovation,90,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Process Innovations,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Product Innovations (Healthcare),80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Product Recalls (Health Care),88,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,R&D Spending,,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,R&D breakout by Innovation Phase,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Risk Culture,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Risk Governance,80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Supplier Code of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Supplier Risk Management Measures,10,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Supply Chain Risk Exposure,88,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Supply Chain Transparency & Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Tax Reporting,10,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Tax Strategy and Governance,0,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Access to Medicine Strategy Reporting,54,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Contribution to Increasing Healthcare Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Corporate Citizenship Strategy,98,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Discrimination & Harassment,90,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Employee Development Programs,90,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Employee Support Programs,65,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Employee Turnover Rate,82,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Fair Pricing,70,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Fatalities,80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Gender Pay Indicators,58,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,HTA Support of Value Proposition,75,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Hiring,75,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Human Capital Return on Investment,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Human Rights Assessment,81,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Human Rights Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Human Rights Due Diligence Process,30,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Human Rights Mitigation & Remediation,33,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Local Capacity Building,90,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Measure Contribution to Health Outcome,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,People Analytics,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Philanthropic Contributions,80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Strategic Workforce Planning,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Training & Development Inputs,90,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Trend of Employee Wellbeing,91,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Type of Philanthropic Activities,50,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Workforce Breakdown: Gender,85,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Workforce Breakdown: Other Minorities,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Dimension,Economic Governance Dimension,78,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Dimension,Environmental Dimension,91,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Dimension,Social Dimension,85,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Climate Strategy,81,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Environmental Policy & Management Systems,77,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Environmental Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Operational Eco-Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Business Ethics,86,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Corporate Governance,73,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Information Security/ Cybersecurity & System Availability,60,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Innovation Management,92,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Marketing Practices,73,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Materiality,93,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Policy Influence,68,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Product Quality & Recall Management,90,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Risk & Crisis Management,82,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Supply Chain Management,82,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Tax Strategy,3,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Access to Healthcare,69,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Addressing Cost Burden,81,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Corporate Citizenship & Philanthropy,81,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Health Outcome Contribution,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Human Capital Development,93,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Human Rights,61,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Labor Practice Indicators,87,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Occupational Health & Safety,79,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Social Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Talent Attraction & Retention,92,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,S&P Global ESG Score,S&P Global ESG Score,82,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Climate Risk Assessment - Transition Risks,15,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Climate-Related Management Incentives,70,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Climate-Related Scenario Analysis,80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Coverage of Environmental Management Policy,80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Direct Greenhouse Gas Emissions (Scope 1),100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,EMS: Certification/ Audit/ Verification,75,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Emissions Reduction Targets,80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Energy Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Financial Opportunities Arising from Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Financial Risks of Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Hazardous Waste,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Physical Climate Risk Adaptation,81,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,TCFD Disclosure,0,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Waste Disposal,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Water Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Anti-Competitive Practices,80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Board Average Tenure,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Board Diversity Policy,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Board Effectiveness,58,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Board Gender Diversity,50,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Board Industry Experience,30,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Board Type,95,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,CEO Compensation - Long-Term Performance Alignment,38,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,CEO Compensation - Success Metrics,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,CEO-to-Employee Pay Ratio,30,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Codes of Conduct: Coverage,89,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Codes of Conduct: Systems/ Procedures,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Compliance to Regulatory Standards,92,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Contributions & Other Spending,83,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Corruption & Bribery,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Corruption & Bribery Cases,80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Critical Supplier Identification,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Direct-to-Consumer Marketing,0,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Dual Class Shares,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,ESG Integration in SCM Strategy,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Effective Tax Rate,0,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Family Ownership,,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Government Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,IT Security/ Cybersecurity Governance,56,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,IT Security/ Cybersecurity Measures,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,IT Security/ Cybersecurity Process & Infrastructure,35,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Largest Contributions & Expenditures,44,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Management Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Management Ownership Requirements,60,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Material Issues for Enterprise Value Creation,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Materiality Analysis,75,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Open Innovation,90,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Process Innovations,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Product Innovations (Healthcare),80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Product Recalls (Health Care),88,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,R&D Spending,,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,R&D breakout by Innovation Phase,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Risk Culture,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Risk Governance,80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Supplier Code of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Supplier Risk Management Measures,10,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Supply Chain Risk Exposure,88,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Supply Chain Transparency & Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Tax Reporting,10,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Tax Strategy and Governance,0,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Access to Medicine Strategy Reporting,54,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Accessibility & Transparency of Outcome Data,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Contribution to Increasing Healthcare Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Corporate Citizenship Strategy,98,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Discrimination & Harassment,90,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Employee Development Programs,90,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Employee Support Programs,65,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Employee Turnover Rate,82,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Fair Pricing,70,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Fatalities,80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Gender Pay Indicators,58,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,HTA Support of Value Proposition,75,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Hiring,75,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Human Capital Return on Investment,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Human Rights Assessment,81,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Human Rights Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Human Rights Due Diligence Process,30,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Human Rights Mitigation & Remediation,33,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Local Capacity Building,90,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Measure Contribution to Health Outcome,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,People Analytics,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Philanthropic Contributions,80,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Strategic Workforce Planning,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Training & Development Inputs,90,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Trend of Employee Wellbeing,91,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Type of Philanthropic Activities,50,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Workforce Breakdown: Gender,85,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Workforce Breakdown: Other Minorities,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Dimension,Economic Governance Dimension,78,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Dimension,Environmental Dimension,91,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Dimension,Social Dimension,85,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Climate Strategy,81,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Environmental Policy & Management Systems,77,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Environmental Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Operational Eco-Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Business Ethics,86,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Corporate Governance,73,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Information Security/ Cybersecurity & System Availability,60,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Innovation Management,92,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Marketing Practices,73,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Materiality,93,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Policy Influence,68,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Product Quality & Recall Management,90,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Risk & Crisis Management,82,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Supply Chain Management,82,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Tax Strategy,3,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Access to Healthcare,69,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Addressing Cost Burden,81,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Corporate Citizenship & Philanthropy,81,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Health Outcome Contribution,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Human Capital Development,93,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Human Rights,61,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Labor Practice Indicators,87,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Occupational Health & Safety,79,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Social Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2021-11-12,Criteria,Talent Attraction & Retention,92,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,S&P Global ESG Score,S&P Global ESG Score,81,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Biodiversity Commitment,0,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Climate Risk Assessment - Transition Risks,15,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Climate-Related Management Incentives,90,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Climate-Related Scenario Analysis,80,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Coverage of Environmental Management Policy,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Direct Greenhouse Gas Emissions (Scope 1),90,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,EMS: Certification/ Audit/ Verification,43,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Emissions Reduction Targets,80,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Energy Consumption,90,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Environmental Policy & Commitments,66,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Financial Opportunities Arising from Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Financial Risks of Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Hazardous Waste,84,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Indirect Greenhouse Gas Emissions (Scope 2),97,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Net-Zero Commitment,0,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,No Deforestation Commitment,0,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Physical Climate Risk Adaptation,81,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,TCFD Disclosure,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Waste Disposal,84,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Water Consumption,30,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Anti-Competitive Practices,80,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Board Average Tenure,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Board Diversity Policy,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Board Effectiveness,58,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Board Gender Diversity,58,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Board Industry Experience,33,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,CEO Compensation - Long-Term Performance Alignment,38,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,CEO Compensation - Success Metrics,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,CEO-to-Employee Pay Ratio,30,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Codes of Conduct: Coverage,89,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Codes of Conduct: Systems/ Procedures,78,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Compliance to Regulatory Standards,93,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Contributions & Other Spending,83,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Corruption & Bribery,60,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Corruption & Bribery Cases,80,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Critical Supplier Identification,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Dual Class Shares,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,ESG Integration in SCM Strategy,60,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Effective Tax Rate,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Family Ownership,,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Government Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,IT Security/ Cybersecurity Governance,38,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,IT Security/ Cybersecurity Measures,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,IT Security/ Cybersecurity Process & Infrastructure,35,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Largest Contributions & Expenditures,88,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Management Ownership,40,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Management Ownership Requirements,60,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Material Issues for Enterprise Value Creation,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Materiality Analysis,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Open Innovation,62,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Process Innovations,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Product Innovations (Healthcare),80,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Product Recalls (Health Care),98,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,R&D Spending,,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,R&D breakout by Innovation Phase,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Risk Culture,74,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Risk Governance,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Supplier Code of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Supplier Risk Management Measures,39,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Supply Chain Risk Exposure,88,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Supply Chain Transparency & Reporting,73,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Tax Reporting,30,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Tax Strategy and Governance,84,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,UN Global Compact Membership,0,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Access to Healthcare Programs (Products & Drugs),100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Accessibility & Transparency of Outcome Data,76,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Contribution to Increasing Healthcare Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Corporate Citizenship Strategy,93,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Direct-to-Consumer Marketing,84,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Discrimination & Harassment,90,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Employee Development Programs,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Employee Support Programs,95,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Fair Pricing,79,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Fatalities,90,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Gender Pay Indicators,38,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,HTA Support of Value Proposition,75,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Hiring,90,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Human Capital Return on Investment,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Human Rights Assessment,75,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Human Rights Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Human Rights Due Diligence Process,30,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Human Rights Mitigation & Remediation,34,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Impact on Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Local Capacity Building,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,93,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Measure Contribution to Health Outcome,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,OHS Policy,32,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,OHS Programs,68,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,People Analytics,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Philanthropic Contributions,80,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Strategic Workforce Planning,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Training & Development Inputs,70,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Trend of Employee Wellbeing,73,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Workforce Breakdown: Gender,85,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Workforce Breakdown: Other Minorities,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Dimension,Economic Governance Dimension,79,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Dimension,Environmental Dimension,66,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Dimension,Social Dimension,87,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Biodiversity,0,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Climate Strategy,73,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Environmental Policy & Management Systems,68,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Environmental Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Operational Eco-Efficiency,83,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Business Ethics,66,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Corporate Governance,72,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Information Security/ Cybersecurity & System Availability,52,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Innovation Management,89,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Materiality,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Policy Influence,85,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Product Quality & Recall Management,95,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Risk & Crisis Management,80,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Supply Chain Management,76,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Tax Strategy,72,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Access to Healthcare,92,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Addressing Cost Burden,84,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Corporate Citizenship & Philanthropy,91,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Health Outcome Contribution,88,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Human Capital Development,91,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Human Rights,60,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Labor Practice Indicators,83,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Marketing Practices,96,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Occupational Health & Safety,75,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Social Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2022-09-23,Criteria,Talent Attraction & Retention,93,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,S&P Global ESG Score,S&P Global ESG Score,75,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Biodiversity Commitment,0,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Climate Risk Assessment - Transition Risks,15,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Climate-Related Management Incentives,90,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Climate-Related Scenario Analysis,80,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Coverage of Environmental Management Policy,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Direct Greenhouse Gas Emissions (Scope 1),90,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,EMS: Certification/ Audit/ Verification,43,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Emissions Reduction Targets,80,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Energy Consumption,90,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Environmental Policy & Commitments,66,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Financial Opportunities Arising from Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Financial Risks of Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Hazardous Waste,84,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Indirect Greenhouse Gas Emissions (Scope 2),97,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Net-Zero Commitment,0,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,No Deforestation Commitment,0,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Physical Climate Risk Adaptation,81,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,TCFD Disclosure,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Waste Disposal,84,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Water Consumption,30,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Anti-Competitive Practices,80,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Board Average Tenure,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Board Diversity Policy,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Board Effectiveness,58,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Board Gender Diversity,58,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Board Industry Experience,33,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,CEO Compensation - Long-Term Performance Alignment,38,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,CEO Compensation - Success Metrics,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,CEO-to-Employee Pay Ratio,30,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Codes of Conduct: Coverage,89,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Codes of Conduct: Systems/ Procedures,78,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Compliance to Regulatory Standards,93,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Contributions & Other Spending,83,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Corruption & Bribery,60,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Corruption & Bribery Cases,80,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Critical Supplier Identification,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Dual Class Shares,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,ESG Integration in SCM Strategy,60,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Effective Tax Rate,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Family Ownership,,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Government Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,IT Security/ Cybersecurity Governance,38,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,IT Security/ Cybersecurity Measures,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,IT Security/ Cybersecurity Process & Infrastructure,35,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Largest Contributions & Expenditures,88,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Management Ownership,40,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Management Ownership Requirements,60,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Material Issues for Enterprise Value Creation,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Materiality Analysis,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Open Innovation,62,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Process Innovations,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Product Innovations (Healthcare),80,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Product Recalls (Health Care),98,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,R&D Spending,,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,R&D breakout by Innovation Phase,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Risk Culture,74,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Risk Governance,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Supplier Code of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Supplier Risk Management Measures,39,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Supply Chain Risk Exposure,88,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Supply Chain Transparency & Reporting,73,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Tax Reporting,30,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Tax Strategy and Governance,84,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,UN Global Compact Membership,0,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Access to Healthcare Programs (Products & Drugs),100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Accessibility & Transparency of Outcome Data,76,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Contribution to Increasing Healthcare Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Corporate Citizenship Strategy,93,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Direct-to-Consumer Marketing,84,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Discrimination & Harassment,90,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Employee Development Programs,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Employee Support Programs,95,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Fair Pricing,79,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Fatalities,90,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Gender Pay Indicators,38,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,HTA Support of Value Proposition,75,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Hiring,90,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Human Capital Return on Investment,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Human Rights Assessment,75,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Human Rights Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Human Rights Due Diligence Process,30,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Human Rights Mitigation & Remediation,34,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Impact on Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Local Capacity Building,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,93,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Measure Contribution to Health Outcome,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,OHS Policy,32,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,OHS Programs,68,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,People Analytics,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Philanthropic Contributions,80,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Strategic Workforce Planning,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Training & Development Inputs,70,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Trend of Employee Wellbeing,73,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Workforce Breakdown: Gender,85,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Workforce Breakdown: Other Minorities,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Dimension,Economic Governance Dimension,75,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Dimension,Environmental Dimension,66,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Dimension,Social Dimension,76,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Biodiversity,0,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Climate Strategy,73,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Environmental Policy & Management Systems,68,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Environmental Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Operational Eco-Efficiency,83,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Business Ethics,36,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Corporate Governance,72,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Information Security/ Cybersecurity & System Availability,52,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Innovation Management,89,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Materiality,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Policy Influence,85,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Product Quality & Recall Management,95,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Risk & Crisis Management,80,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Supply Chain Management,76,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Tax Strategy,72,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Access to Healthcare,92,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Addressing Cost Burden,84,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Corporate Citizenship & Philanthropy,91,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Health Outcome Contribution,48,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Human Capital Development,91,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Human Rights,33,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Labor Practice Indicators,83,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Marketing Practices,52,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Occupational Health & Safety,75,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Social Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Talent Attraction & Retention,93,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,S&P Global ESG Score,S&P Global ESG Score,75,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Biodiversity Commitment,0,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Climate Risk Assessment - Transition Risks,15,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Climate-Related Management Incentives,90,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Climate-Related Scenario Analysis,80,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Coverage of Environmental Management Policy,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Direct Greenhouse Gas Emissions (Scope 1),90,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,EMS: Certification/ Audit/ Verification,43,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Emissions Reduction Targets,80,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Energy Consumption,90,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Environmental Policy & Commitments,66,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Environmental Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Financial Opportunities Arising from Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Financial Risks of Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Hazardous Waste,84,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Indirect Greenhouse Gas Emissions (Scope 2),97,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Net-Zero Commitment,0,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,No Deforestation Commitment,0,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Physical Climate Risk Adaptation,81,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,TCFD Disclosure,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Waste Disposal,84,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Water Consumption,30,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Anti-Competitive Practices,80,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Board Average Tenure,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Board Diversity Policy,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Board Effectiveness,58,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Board Gender Diversity,58,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Board Industry Experience,33,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,CEO Compensation - Long-Term Performance Alignment,38,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,CEO Compensation - Success Metrics,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,CEO-to-Employee Pay Ratio,30,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Codes of Conduct: Coverage,89,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Codes of Conduct: Systems/ Procedures,78,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Compliance to Regulatory Standards,93,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Contributions & Other Spending,83,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Corruption & Bribery,60,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Corruption & Bribery Cases,80,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Critical Supplier Identification,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Dual Class Shares,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,ESG Integration in SCM Strategy,60,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Effective Tax Rate,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Family Ownership,,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Government Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,IT Security/ Cybersecurity Governance,38,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,IT Security/ Cybersecurity Measures,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,IT Security/ Cybersecurity Process & Infrastructure,35,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Largest Contributions & Expenditures,88,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Management Ownership,40,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Management Ownership Requirements,60,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Material Issues for Enterprise Value Creation,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Materiality Analysis,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Open Innovation,62,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Process Innovations,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Product Innovations (Healthcare),80,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Product Recalls (Health Care),98,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,R&D Spending,,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,R&D breakout by Innovation Phase,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Risk Culture,74,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Risk Governance,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Sensitivity Analysis & Stress Testing (including Water an,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Supplier Code of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Supplier Risk Management Measures,39,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Supply Chain Risk Exposure,88,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Supply Chain Transparency & Reporting,73,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Tax Reporting,30,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Tax Strategy and Governance,84,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,UN Global Compact Membership,0,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Access to Healthcare Programs (Products & Drugs),100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Accessibility & Transparency of Outcome Data,76,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Contribution to Increasing Healthcare Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Corporate Citizenship Strategy,93,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Direct-to-Consumer Marketing,84,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Discrimination & Harassment,90,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Employee Development Programs,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Employee Support Programs,95,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Fair Pricing,79,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Fatalities,90,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Gender Pay Indicators,38,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,HTA Support of Value Proposition,75,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Hiring,90,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Human Capital Return on Investment,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Human Rights Assessment,75,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Human Rights Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Human Rights Due Diligence Process,30,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Human Rights Mitigation & Remediation,34,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Impact on Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Local Capacity Building,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,93,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Measure Contribution to Health Outcome,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,OHS Policy,32,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,OHS Programs,68,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,People Analytics,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Philanthropic Contributions,80,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Social Reporting - Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Social Reporting - Coverage,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Strategic Workforce Planning,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Training & Development Inputs,70,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Trend of Employee Wellbeing,73,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Type of Performance Appraisal,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Type of Philanthropic Activities,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Workforce Breakdown: Gender,85,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Workforce Breakdown: Other Minorities,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Dimension,Economic Governance Dimension,75,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Dimension,Environmental Dimension,66,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Dimension,Social Dimension,76,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Biodiversity,0,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Climate Strategy,73,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Environmental Policy & Management Systems,68,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Environmental Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Operational Eco-Efficiency,83,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Business Ethics,36,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Corporate Governance,72,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Information Security/ Cybersecurity & System Availability,52,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Innovation Management,89,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Materiality,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Policy Influence,85,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Product Quality & Recall Management,95,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Risk & Crisis Management,80,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Supply Chain Management,76,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Tax Strategy,72,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Access to Healthcare,92,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Addressing Cost Burden,84,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Corporate Citizenship & Philanthropy,91,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Health Outcome Contribution,48,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Human Capital Development,91,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Human Rights,33,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Labor Practice Indicators,83,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Marketing Practices,52,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Occupational Health & Safety,75,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Social Reporting,100,016101,ABBV,AbbVie Inc.
4558282,2023-01-20,Criteria,Talent Attraction & Retention,93,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,S&P Global ESG Score,S&P Global ESG Score,68,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Biodiversity Commitment,0,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Biodiversity Risk Assessment,38,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Climate Governance,70,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Climate-Related Management Incentives,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Climate-Related Scenario Analysis,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Coverage of Environmental Management Policy,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Direct Greenhouse Gas Emissions (Scope 1),100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,EMS: Certification/ Audit/ Verification,58,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Emissions Reduction Targets,70,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Energy Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Environmental Policy & Commitments,66,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Exposure to Hazardous Substances,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Financial Opportunities Arising from Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Financial Risks of Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Hazardous Waste,90,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 3),75,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Life Cycle Assessment,51,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Net-Zero Commitment,0,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,No Deforestation Commitment,0,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Physical Climate Risk Adaptation,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Product Design Criteria,48,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,TCFD Disclosure,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Waste Disposal,80,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Water Consumption,90,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Board Average Tenure,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Board Diversity Policy,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Board Effectiveness,58,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Board Gender Diversity,58,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Board Independence,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Board Industry Experience,33,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,CEO Compensation - Long-Term Performance Alignment,38,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,CEO Compensation - Success Metrics,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,CEO-to-Employee Pay Ratio,30,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Codes of Conduct: Systems/ Procedures,78,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Compliance to Regulatory Standards,96,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Contributions & Other Spending,83,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Corruption & Bribery,60,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Effective Tax Rate,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Family Ownership,,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Government Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,IT Security/ Cybersecurity Governance,75,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,IT Security/ Cybersecurity Measures,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,IT Security/ Cybersecurity Process & Infrastructure,55,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,KPIs for Supplier Assessment and Development,19,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,KPIs for Supplier Screening,76,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Largest Contributions & Expenditures,88,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Lobbying and Trade Associations - Climate Alignment,0,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Management Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Management Ownership Requirements,60,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Material Issues for Enterprise Value Creation,84,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Material Issues for External Stakeholders,95,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Materiality Analysis,50,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Materiality Metrics for Enterprise Value Creation,40,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Materiality Metrics for External Stakeholders,8,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Open Innovation,90,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Process Innovations,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Product Innovations (Healthcare),80,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Product Recalls (Health Care),97,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,R&D Spending,,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,R&D breakout by Innovation Phase,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Risk Culture,84,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Risk Governance,30,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Risk Management Processes,35,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Supplier Assessment and Development,35,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Supplier Code of Conduct,76,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Supplier ESG Program,50,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Supplier Screening,39,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Sustainability Reporting Boundaries,75,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Sustainability Taxonomies,,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Tax Reporting,30,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Tax Strategy and Governance,84,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,UN Global Compact Membership,0,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Access to Healthcare Programs (Products & Drugs),100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Accessibility & Transparency of Outcome Data,76,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Contribution to Increasing Healthcare Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Direct-to-Consumer Marketing,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Discrimination & Harassment,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Employee Development Programs,38,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Employee Support Programs,91,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Fair Pricing,79,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Fatalities,90,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Gender Pay Indicators,54,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,HTA Support of Value Proposition,75,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Hiring,90,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Human Capital Return on Investment,0,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Human Rights Assessment,82,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Human Rights Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Human Rights Due Diligence Process,30,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Human Rights Mitigation & Remediation,34,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Impact on Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Local Capacity Building,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Measure Contribution to Health Outcome,93,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,OHS Policy,44,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,OHS Programs,84,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Training & Development Inputs,38,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Trend of Employee Wellbeing,61,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Type of Performance Appraisal,85,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Workforce Breakdown: Gender,88,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Dimension,Economic Governance Dimension,68,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Dimension,Environmental Dimension,71,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Dimension,Social Dimension,67,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Biodiversity,8,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Climate Strategy,78,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Environmental Policy & Management Systems,74,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Product Stewardship,70,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Business Ethics,31,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Corporate Governance,74,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Information Security/ Cybersecurity & System Availability,77,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Innovation Management,92,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Materiality,56,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Policy Influence,75,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Product Quality & Recall Management,97,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Risk & Crisis Management,44,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Supply Chain Management,46,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Tax Strategy,72,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Access to Healthcare,92,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Addressing Cost Burden,84,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Health Outcome Contribution,46,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Human Capital Development,26,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Human Rights,34,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Labor Practice Indicators,86,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Marketing Practices,55,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Occupational Health & Safety,84,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Talent Attraction & Retention,88,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,S&P Global ESG Score,S&P Global ESG Score,68,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Biodiversity Commitment,0,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Biodiversity Risk Assessment,38,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Climate Governance,70,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Climate Risk Management,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Climate-Related Management Incentives,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Climate-Related Scenario Analysis,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Coverage of Environmental Management Policy,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Direct Greenhouse Gas Emissions (Scope 1),100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,EMS: Certification/ Audit/ Verification,58,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Emissions Reduction Targets,70,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Energy Consumption,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Environmental Policy & Commitments,66,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Exposure to Hazardous Substances,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Financial Opportunities Arising from Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Financial Risks of Climate Change,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Hazardous Waste,90,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 3),75,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Life Cycle Assessment,51,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Net-Zero Commitment,0,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,No Deforestation Commitment,0,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Physical Climate Risk Adaptation,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Product Design Criteria,48,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,TCFD Disclosure,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Waste Disposal,80,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Water Consumption,90,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Board Average Tenure,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Board Diversity Policy,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Board Effectiveness,58,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Board Gender Diversity,58,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Board Independence,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Board Industry Experience,33,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Board Type,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,CEO Compensation - Long-Term Performance Alignment,38,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,CEO Compensation - Success Metrics,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,CEO-to-Employee Pay Ratio,30,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Codes of Conduct,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Codes of Conduct: Systems/ Procedures,78,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Compliance to Regulatory Standards,96,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Contributions & Other Spending,83,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Corruption & Bribery,60,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Effective Tax Rate,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Emerging Risks,0,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Family Ownership,,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Government Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,IT Security/ Cybersecurity Governance,75,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,IT Security/ Cybersecurity Measures,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,IT Security/ Cybersecurity Process & Infrastructure,55,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,KPIs for Supplier Assessment and Development,19,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,KPIs for Supplier Screening,76,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Largest Contributions & Expenditures,88,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Lobbying and Trade Associations - Climate Alignment,0,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Management Ownership,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Management Ownership Requirements,60,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Material Issues for Enterprise Value Creation,84,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Material Issues for External Stakeholders,95,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Materiality Analysis,50,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Materiality Metrics for Enterprise Value Creation,40,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Materiality Metrics for External Stakeholders,8,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Non-Executive Chairperson/ Lead Director,60,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Open Innovation,90,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Process Innovations,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Product Innovations (Healthcare),80,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Product Recalls (Health Care),97,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,R&D Spending,,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,R&D breakout by Innovation Phase,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Reporting on breaches,0,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Risk Culture,84,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Risk Governance,30,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Risk Management Processes,35,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Supplier Assessment and Development,35,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Supplier Code of Conduct,76,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Supplier ESG Program,50,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Supplier Screening,39,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Sustainability Reporting Assurance,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Sustainability Reporting Boundaries,75,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Sustainability Taxonomies,,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Tax Reporting,30,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Tax Strategy and Governance,84,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,UN Global Compact Membership,0,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Access to Healthcare Programs (Products & Drugs),100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Accessibility & Transparency of Outcome Data,76,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Contribution to Increasing Healthcare Efficiency,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Direct-to-Consumer Marketing,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Discrimination & Harassment,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Employee Development Programs,38,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Employee Support Programs,91,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Employee Turnover Rate,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Ethical Marketing - Complaints Tracking,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Ethical Marketing Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Fair Pricing,79,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Fatalities,90,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Freedom of Association,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Gender Pay Indicators,54,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,HTA Support of Value Proposition,75,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Hiring,90,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Human Capital Return on Investment,0,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Human Rights Assessment,82,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Human Rights Commitment,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Human Rights Due Diligence Process,30,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Human Rights Mitigation & Remediation,34,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Impact on Access to Healthcare,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Local Capacity Building,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Long-Term Incentives for Employees,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Measure Contribution to Health Outcome,93,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,OHS Policy,44,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,OHS Programs,84,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Patent Filing Policy,60,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Training & Development Inputs,38,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Trend of Employee Wellbeing,61,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Type of Performance Appraisal,85,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Workforce Breakdown: Gender,88,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Dimension,Economic Governance Dimension,68,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Dimension,Environmental Dimension,71,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Dimension,Social Dimension,67,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Biodiversity,8,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Climate Strategy,78,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Environmental Policy & Management Systems,74,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Product Stewardship,70,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Business Ethics,31,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Corporate Governance,74,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Information Security/ Cybersecurity & System Availability,77,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Innovation Management,92,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Materiality,56,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Policy Influence,75,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Product Quality & Recall Management,97,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Risk & Crisis Management,44,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Supply Chain Management,46,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Tax Strategy,72,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Access to Healthcare,92,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Addressing Cost Burden,84,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Health Outcome Contribution,46,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Human Capital Development,26,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Human Rights,34,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Labor Practice Indicators,86,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Marketing Practices,55,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Occupational Health & Safety,84,016101,ABBV,AbbVie Inc.
4558282,2023-10-27,Criteria,Talent Attraction & Retention,88,016101,ABBV,AbbVie Inc.
